NewcelX Ltd. (NCEL:NASDAQ) closed at $2.66 on October 23, 2026, up 3.91% on the day. The stock trades 80.4% below its 52-week high of $13.60 and 45.4% above its 52-week low of $1.83. Over the past year, it lost 79.5%. NewcelX Ltd. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, NCEL closed higher on 104 days (41%). Its best day was April 23, 2026 (+34.15%) and its worst was October 29, 2025 (-29.52%). The stock moved 10% or more in a single session 31 times. It opened at least 5% above the previous day's high 5 times.
At NewcelX, we leverage our combined strengths in advanced cell therapy solutions and innovative approaches in metabolic interventions to treat complex medical needs, positioning ourselves for unprecedented growth in the biotechnology sector. Our expertise enables us to address multifaceted conditions such as amyotrophic lateral sclerosis (ALS), other neurodegenerative diseases and insulin-dependent diabetes, ensuring we deliver comprehensive, patient-centered solutions.Driving scientific innovation is at the heart of NewcelX. By pooling our research and development efforts, we accelerate breakthroughs in the science. This focus enhances the quality of our product offerings while expediting the development process, for unmet medical needs.As we continue to grow, NewcelX is dedicated to creating synergistic therapies that promise a broader impact on patients' lives.
Find more stocks like NCEL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.